Purchase Order 75N92E23P00223
Award Date
8/7/23
Potential Completion Date
12/31/23
Potential Value
Not listed
Federal Agency
National Human Genome Research Institute
Awardee
Alstem, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Pablo, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute to Alstem, Inc., a minority-owned, for-profit small business, for $49,800.00. The contract is for services to generate human induced pluripotent stem (iPS) cells using episomal vector technology, in support of the agency's stem cell research and development efforts. Alstem, which specializes in induced...
This is a $15,375 firm-fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to the New York Stem Cell Foundation, Inc., a non-profit organization. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells,...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Applied Stemcell, Inc., a minority-owned, woman-owned small business, for a firm-fixed-price purchase order in the amount of $63,000.00. The contract calls for the use of CRISPR gene editing technology to create two custom induced pluripotent stem cell (iPSC) reporter cell lines - one with dual gene knock-ins for albumin and alpha-fetoprotein, and...
This is a $13,760 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Applied Stemcell, Inc. for the generation of point mutation induced pluripotent stem (iPS) or embryonic stem (ES) cell lines using CRISPR/Cas9 gene editing technology. The work is to be performed in Bethesda, MD and has a completion date of March 31, 2022. Applied Stemcell, Inc. is a minority-owned, woman-owned small business that provides...
The National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a firm-fixed price purchase order valued at $3.4 million to New York Stem Cell Foundation Inc. The contract calls for the contractor to generate up to 200 induced pluripotent stem cell lines derived from fresh whole blood or peripheral blood mononuclear cells of patients with Alzheimer's disease or related dementias. The cell lines must be collected by...
This $238,000.00 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to the New York Stem Cell Foundation, Inc., a non-profit organization that conducts stem cell research. The contract is for the derivation of induced pluripotent stem cells, which aligns with the foundation's work in generating stem cell lines, differentiating them into various cell types, and...
The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded a $125,135 firm fixed price delivery order contract to Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, to generate induced pluripotent stem cell lines. Under the contract, Life Technologies will produce stem cell lines for the agency through October 9, 2022. The award was made without a set-aside designation on May 9, 2022. As the preeminent federal sponsor...
This federal contract award from the National Human Genome Research Institute, an agency within the U.S. Department of Health and Human Services, was made to the New York Stem Cell Foundation Inc., a non-profit organization that conducts stem cell research. The contract, valued at $425,000.00, is for the generation of 50 induced pluripotent stem cell (iPSC) lines from fusion study fibroblast cell lines. No set-aside designation was used for this contract. The New York Stem Cell Foundation Inc....
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Applied Stemcell, Inc., a minority owned, woman owned small business. The $17,400.00 Firm Fixed Price contract is for the investigation of cellular dysfunction associated with hereditary mutation within the prion gene, insertion of the gene mutation (D178N) into a 'normal' cell background, with production of heterozygous insert...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $224,000.00 firm fixed price purchase order contract to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for the foundation to provide services including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells, and expanding,...